Skip to main content

Table 4 Results of sensitivity analyses

From: Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial

 Sample size per groupIncremental effectIncremental costsICERDominanceProbability cost-effective (WTPa €20,000/QALY)Probability cost-effective (WTPa €80,000/QALY)
Societal perspective1451430.0254728.094304370
Health care perspective1451430.0226513.605265681
Complete cases1231190.0260024.586324875
Reduced intervention costs1451430.0241421.266344773
  1. aWTP Willingness to pay